Dr Rebecca Lee

NIHR Clinical Lecturer

Affiliations:
ORCID: 0000-0003-2540-2009
View graph of relations

Related information

Publications

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers.

Research output: Contribution to journal › Article › peer-review

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Research output: Contribution to journal › Article › peer-review

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Research output: Contribution to journal › Article › peer-review

View all (24)

Media coverage and contribution

Simple blood test could reveal return of skin cancer

Press/Media: Research

View all (1)

Prizes

Association of Cancer Physicians McElwain prize for translational research project

Prize: Prize (including medals and awards)

View all prizes (1)